STOCKHOLDERS’ EQUITY (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of black scholes option pricing model using assumptions |
| Schedule of black scholes option pricing model using assumptions
|
|
|
|
| |
|
At September 30, 2025
|
|
| Grant date share price |
|
|
$7.11 - $7.26 |
|
| Grant date exercise price |
|
|
$5.64 - $6.17 |
|
| Expected term |
|
|
0.25 years - 0.5 years |
|
| Expected volatility |
|
|
69.5% - 105.3 |
% |
| Risk-free rate |
|
|
4.02% - 4.32 |
% |
| Expected dividend rate |
|
|
0 |
% |
|
| Schedule of stock-based compensation |
| Schedule of stock-based compensation
|
|
|
|
| |
|
For the Nine Months ended
September 30, 2025 |
|
| Cash payment received from employee withholding |
|
$ |
173,102 |
|
| Cash from employee withholdings used to purchase shares under ESPP |
|
|
(114,724 |
) |
| Accrued employee withholdings at
September 30, 2025 |
|
$ |
58,378 |
|
| |
|
|
|
| |
|
For the Nine Months ended
September 30, 2025 |
|
| Cash from employee withholdings used to purchase ESPP shares |
|
$ |
114,724 |
|
| Stock based compensation expense |
|
|
88,986 |
|
| Total increase to equity for nine months ended September 30, 2025 |
|
$ |
203,710 |
|
| |
|
|
|
| |
|
For the Nine Months ended
September 30, 2024 |
|
| Cash from employee withholdings used to purchase ESPP shares |
|
$ |
123,359 |
|
| Stock based compensation expense |
|
|
54,833 |
|
Total increase to equity for nine months ended September 30, 2024 |
|
$ |
178,192 |
|
|
| Schedule of options |
| Schedule of options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Number of
Options |
|
|
Weighted
Average
Exercise
Price |
|
|
Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
| Outstanding at December 31, 2023 |
|
|
|
1,387,775 |
|
|
$ |
5.23 |
|
|
|
3.0 |
|
|
$ |
— |
|
| Granted |
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| Forfeited |
|
|
|
(781,323 |
) |
|
$ |
5.17 |
|
|
|
— |
|
|
$ |
— |
|
| Outstanding at December 31, 2024 |
|
|
|
606,452 |
|
|
$ |
5.29 |
|
|
|
2.0 |
|
|
$ |
514,394 |
|
| Exercisable at December 31, 2024 |
|
|
|
442,445 |
|
|
$ |
5.50 |
|
|
|
1.6 |
|
|
$ |
296,145 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding at December 31, 2024 |
|
|
|
606,452 |
|
|
$ |
5.29 |
|
|
|
2.0 |
|
|
$ |
514,394 |
|
| Granted |
|
|
|
20,000 |
|
|
$ |
5.64 |
|
|
|
4.5 |
|
|
$ |
34,400 |
|
| Exercised/Forfeited/Expired |
|
|
|
(141,327 |
) |
|
$ |
5.31 |
|
|
|
— |
|
|
$ |
— |
|
| Outstanding at September 30, 2025 |
|
|
|
485,125 |
|
|
$ |
5.30 |
|
|
|
1.9 |
|
|
$ |
997,153 |
|
| Exercisable at September 30, 2025 |
|
|
|
386,456 |
|
|
$ |
5.51 |
|
|
|
1.6 |
|
|
$ |
715,732 |
|
|
| Schedule of assumptions in determining the fair value of the warrants |
| Schedule of assumptions in determining the fair value of the warrants |
|
|
|
|
|
|
| |
|
|
Upon Grant |
|
| |
|
|
Titan |
|
|
|
Titan |
|
| Date of Grant |
|
|
August 1, 2025 |
|
|
|
September 2, 2025 |
|
| Stock Price |
|
$ |
6.57 |
|
|
$ |
6.25 |
|
| Exercise Price |
|
$ |
7.20 |
|
|
$ |
7.20 |
|
| Expected Remaining Term (Years) |
|
|
5.00 |
|
|
|
5.00 |
|
| Historical Volatility |
|
|
73 |
% |
|
|
55 |
% |
| Expected Volatility |
|
|
36 |
% |
|
|
33 |
% |
| Dividend Yield |
|
|
0 |
% |
|
|
0 |
% |
| Annual Rate of Quarterly Dividends |
|
$ |
0.000 |
|
|
$ |
0.000 |
|
| Discount Rate - Bond Equivalent Yield |
|
|
3.770 |
% |
|
|
3.740 |
% |
|
| Schedule of warrants |
| Schedule of warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number of
Warrants |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
| Outstanding at December 31, 2023 |
|
|
44,644 |
|
|
$ |
7.70 |
|
|
|
0.7 |
|
|
$ |
— |
|
| Warrants expired, forfeited, cancelled or exercised |
|
|
(344,644 |
) |
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| Warrants issued |
|
|
300,000 |
|
|
$ |
3.00 |
|
|
|
— |
|
|
$ |
— |
|
| Outstanding at December 31, 2024 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| Exercisable at December 31, 2024 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding at December 31, 2024 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| Warrants issued |
|
|
375,276 |
|
|
$ |
7.20 |
|
|
|
5.0 |
|
|
$ |
— |
|
| Warrants expired, forfeited, cancelled or exercised |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
| Outstanding at September 30, 2025 |
|
|
375,276 |
|
|
$ |
7.20 |
|
|
|
4.8 |
|
|
$ |
60,044 |
|
| Exercisable at September 30, 2025 |
|
|
375,276 |
|
|
$ |
7.20 |
|
|
|
4.8 |
|
|
$ |
60,044 |
|
|
| Schedule of restricted stock unit |
| Schedule of restricted stock unit
|
|
|
|
|
|
|
| |
|
Number of
Shares |
|
|
Weighted
Average
Grant
Date Fair Value Per Share |
|
| Unvested at December 31, 2023 |
|
— |
|
|
$ |
— |
|
| Restricted stock forfeited |
|
— |
|
|
$ |
— |
|
| Restricted stock granted |
|
— |
|
|
$ |
— |
|
| Unvested at December 31, 2024 |
|
— |
|
|
$ |
— |
|
| Vested at December 31, 2024 |
|
— |
|
|
$ |
— |
|
| |
|
|
|
|
|
|
| Unvested at December 31, 2024 |
|
|
— |
|
|
$ |
— |
|
| Restricted stock granted |
|
|
2,146,898 |
|
|
$ |
6.13 |
|
| Restricted stock forfeited |
|
|
(112,500 |
) |
|
$ |
5.98 |
|
| Restricted stock vested |
|
|
(20,000 |
) |
|
$ |
5.22 |
|
| Unvested at September 30, 2025 |
|
|
2,014,398 |
|
|
$ |
6.14 |
|
| Vested at September 30, 2025 |
|
|
20,000 |
|
|
$ |
5.22 |
|
|